Synaptogenix Inc (SNPX)
4.76
-0.07
(-1.45%)
USD |
NASDAQ |
May 23, 10:29
Synaptogenix Total Assets (Quarterly): 29.40M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 29.40M |
| December 31, 2023 | 31.11M |
| September 30, 2023 | 32.36M |
| June 30, 2023 | 33.44M |
| March 31, 2023 | 36.53M |
| December 31, 2022 | 38.61M |
| September 30, 2022 | 27.35M |
| June 30, 2022 | 29.58M |
| Date | Value |
|---|---|
| March 31, 2022 | 32.35M |
| December 31, 2021 | 35.52M |
| September 30, 2021 | 32.36M |
| June 30, 2021 | 32.96M |
| March 31, 2021 | 16.35M |
| December 31, 2020 | 6.751M |
| September 30, 2020 | 29.15M |
| December 31, 2019 | 17.90M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
6.751M
Minimum
Dec 2020
38.61M
Maximum
Dec 2022
28.86M
Average
31.73M
Median
Total Assets (Quarterly) Benchmarks
| CEL-SCI Corp | 30.05M |
| AIM ImmunoTech Inc | 16.19M |
| IGC Pharma Inc | 11.26M |
| NovaBay Pharmaceuticals Inc | 5.357M |
| Protalix BioTherapeutics Inc | 89.82M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.523M |
| Shareholders Equity (Quarterly) | 22.88M |